Sanofi

🇫🇷France

Country: 🇫🇷France

Ownership: Public

Employees: 87.9K

Market Cap: $141.3B

Website: http://www.sanofi.com

Introduction: Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Clinical Trials

Lantus Versus Levemir Treat-To-Target

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Insulin glargine
Drug: Insulin Detemir

First Posted Date: 2006-11-30

Last Posted Date: 2009-09-15

Lead Sponsor: Sanofi

Target Recruit Count: 973

Registration Number: NCT00405418

Locations: 🇬🇧
Sanofi-Aventis, Guildford, United Kingdom

Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose

Phase 3

Terminated

Conditions: Obesity

Interventions: Drug: Rimonabant
Drug: Placebo

First Posted Date: 2006-11-30

Last Posted Date: 2011-01-26

Lead Sponsor: Sanofi

Target Recruit Count: 2666

Registration Number: NCT00405808

Locations: 🇬🇧
Sanofi-Aventis Administrative Office, Guildford Surrey, United Kingdom

Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer

Phase 1

Completed

Conditions: Rectal Neoplasms

First Posted Date: 2006-11-27

Last Posted Date: 2010-08-27

Lead Sponsor: Sanofi

Target Recruit Count: 38

Registration Number: NCT00403624

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

Phase 4

Completed

Conditions: Osteoporosis, Postmenopausal

First Posted Date: 2006-11-22

Last Posted Date: 2009-04-29

Lead Sponsor: Sanofi

Target Recruit Count: 260

Registration Number: NCT00402441

Locations: 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States

Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

Phase 4

Completed

Conditions: Prostatic Hyperplasia

Interventions: Drug: Alfuzosin

First Posted Date: 2006-11-20

Last Posted Date: 2009-09-15

Lead Sponsor: Sanofi

Target Recruit Count: 110

Registration Number: NCT00401661

Locations: 🇹🇭
Sanofi-Aventis, Bangkok, Thailand

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase 2

Completed

Conditions: Head and Neck Neoplasms
Neoplasm Recurrence, Local
Neoplasm Metastasis

Interventions: Drug: docetaxel (XRP6976)
Drug: cisplatin
Drug: 5-fluorouracil (5-FU)

First Posted Date: 2006-11-20

Last Posted Date: 2011-01-20

Lead Sponsor: Sanofi

Target Recruit Count: 568

Registration Number: NCT00401323

Locations: 🇿🇦
sanofi-aventis South Africa, Midrand, South Africa
🇫🇷
sanofi-aventis, France, Paris, France
🇭🇺
Sanofi-Aventis Hungaria, Budapest, Hungary

and more 10 locations